Stay updated on Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.

Latest updates to the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA notice was added about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with a standard error page. The additions reflect the 403 message, basic HTML boilerplate, and a Home link in the header/footer.SummaryDifference19%

- Check46 days agoChange DetectedThe page revision tag was updated from v3.6.6 to v3.7.0, signaling a new revision without changes to the study content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now shows Revision: v3.6.6 instead of v3.6.5, signaling a new software release. This update typically accompanies minor fixes or improvements and does not alter the displayed study information.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a new version of the page. This update reflects a version bump rather than changes to the study data.SummaryDifference0.0%

Stay in the know with updates to Glesatinib Combo With Nivolumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Glesatinib Combo With Nivolumab in NSCLC Clinical Trial page.